The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The industry rank for POINT Biopharma Global's 9-Day RSI or its related term are showing as below:
PNT's 9-Day RSI is not ranked
in the Biotechnology industry.
Industry Median: 43.69
vs PNT: 28.24
Competitive Comparison of POINT Biopharma Global's 9-Day RSI
For the Biotechnology subindustry, POINT Biopharma Global's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
POINT Biopharma Global's 9-Day RSI Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, POINT Biopharma Global's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where POINT Biopharma Global's 9-Day RSI falls into.
POINT Biopharma Global (NAS:PNT) 9-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
POINT Biopharma Global (NAS:PNT) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
POINT Biopharma Global 9-Day RSI Related Terms
Thank you for viewing the detailed overview of POINT Biopharma Global's 9-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.
POINT Biopharma Global (POINT Biopharma Global) Business Description
POINT Biopharma Global Inc is a clinical-stage pharmaceutical company focused on the development and commercialization of radioligand therapies for the treatment of cancer. Its product pipeline includes PNT2002; PNT2004; PNT2003; PNT2001 and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PNT has been successfully added to your